维布妥昔单抗联合化疗治疗32例恶性淋巴瘤的临床观察.Published in:Cancer Research on Prevention & Treatment, 2023, v. 50, n. 3, p. 288, doi. 10.3971/j.issn.1000-8578.2023.22.1235By:柴笑菲;乔泓涵;张蕾;李鑫;李玲;王新华;付晓瑞;张旭东;孙振昌;南飞飞;张明智Publication type:Article